Harvard Bioscience (HBIO) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.07% |
| Dec 31, 2025 | -14.52% |
| Sep 30, 2025 | -55.90% |
| Jun 30, 2025 | -34.18% |
| Mar 31, 2025 | -5.43% |
| Dec 31, 2024 | 2.70% |
| Sep 30, 2024 | -33.96% |
| Jun 30, 2024 | -27.17% |
| Mar 31, 2024 | 12.14% |
| Dec 31, 2023 | 11.22% |
| Sep 30, 2023 | -27.11% |
| Jun 30, 2023 | -31.84% |
| Mar 31, 2023 | 2.64% |
| Dec 31, 2022 | 2.42% |
| Sep 30, 2022 | 4.07% |
| Jun 30, 2022 | 8.93% |
| Mar 31, 2022 | 3.46% |
| Dec 31, 2021 | 2.77% |
| Sep 30, 2021 | 1.26% |
| Jun 30, 2021 | 5.30% |
| Mar 31, 2021 | 9.07% |
| Dec 31, 2020 | 7.34% |
| Sep 30, 2020 | 6.79% |
| Jun 30, 2020 | 2.13% |
| Mar 31, 2020 | 6.46% |
| Dec 31, 2019 | 6.22% |
| Sep 30, 2019 | 9.92% |
| Jun 30, 2019 | 5.44% |
| Mar 31, 2019 | 5.74% |
| Dec 31, 2018 | 3.92% |
| Sep 30, 2018 | -8.63% |
| Jun 30, 2018 | 4.54% |
| Mar 31, 2018 | 9.29% |
| Dec 31, 2017 | -1.12% |
| Sep 30, 2017 | -0.53% |
| Jun 30, 2017 | 2.39% |
| Mar 31, 2017 | 4.37% |
| Dec 31, 2016 | 2.43% |
| Sep 30, 2016 | 2.00% |
| Jun 30, 2016 | 6.44% |
| Mar 31, 2016 | 6.44% |
| Dec 31, 2015 | -1.57% |
| Sep 30, 2015 | 0.47% |